We are live on
!
Find out more
HP
Hikari Power Portfolio holdings
AUM
$855M
Turnover
22.64%
1-Year Est. Return
14.24%
This Fund
S&P 500
This Quarter
Est. Return
-2.13%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$850M
AUM Growth
+$2.81M
(+0.33%)
Cap. Flow
+$26.1M
Cap. Flow
% of AUM
3.07%
Top 10 Holdings %
Top 10 Hldgs %
59.06%
Holding
107
New
6
Increased
20
Reduced
2
Closed
10
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutrien
NTR
|
+$18.8M |
| 2 |
GE Aerospace
GE
|
+$3.66M |
| 3 |
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
|
+$2.86M |
| 4 |
Johnson & Johnson
JNJ
|
+$2.45M |
| 5 |
iShares Biotechnology ETF
IBB
|
+$2.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
POT
Potash Corp Of Saskatchewan
POT
|
+$19.4M |
| 2 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$614K |
| 3 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$593K |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$377K |
| 5 |
Somnigroup International
SGI
|
+$273K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.2% |
| 2 | Healthcare | 24.75% |
| 3 | Industrials | 10.98% |
| 4 | Technology | 10.54% |
| 5 | Materials | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
McDonald's
MCD
$172B
| $1.57M | 0.19% |
10,060
| – | – |
2014 Q4
13 quarters
|
|
|
PGNX
52
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.49M | 0.18% |
200,000
| – | – |
2017 Q3
2 quarters
|
|
|
CHL
53
DELISTED
China Mobile Limited
CHL
| $1.36M | 0.16% |
+29,800
| New | +$1.45M |
2018 Q1
0 quarters
|
|
|
CBI
54
DELISTED
Chicago Bridge & Iron Nv
CBI
| $1.34M | 0.16% |
93,000
| – | – |
2014 Q3
14 quarters
|
|
55
Altria Group
MO
$125B
| $1.32M | 0.16% |
+21,200
| New | +$1.4M |
2018 Q1
0 quarters
|
|
56
United Therapeutics
UTHR
$22.9B
| $1.29M | 0.15% |
11,490
| – | – |
2016 Q3
6 quarters
|
|
57
Akari Therapeutics
AKTX
$18.7M
| $1.16M | 0.14% |
795
+606
| +321% | +$1.31M |
2017 Q2
3 quarters
|
|
|
BDSI
58
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.13M | 0.13% |
500,000
-101,285
| -17% | -$237K |
2017 Q1
4 quarters
|
|
59
AB InBev
BUD
$163B
| $1.11M | 0.13% |
10,100
| – | – |
2015 Q3
10 quarters
|
|
60
Sensata Technologies
ST
$5.91B
| $933K | 0.11% |
+18,000
| New | +$960K |
2018 Q1
0 quarters
|
|
|
STOR
61
DELISTED
STORE Capital Corporation
STOR
| $911K | 0.11% |
36,700
| – | – |
2017 Q3
2 quarters
|
|
62
Acadia Pharmaceuticals
ACAD
$3.29B
| $899K | 0.11% |
40,000
| – | – |
2016 Q4
5 quarters
|
|
|
AMAG
63
DELISTED
AMAG Pharmaceuticals
AMAG
| $880K | 0.1% |
43,691
-36,309
| -45% | -$614K |
2017 Q1
4 quarters
|
|
64
Aldeyra Therapeutics
ALDX
$42.2M
| $809K | 0.1% |
107,858
| – | – |
2017 Q1
4 quarters
|
|
|
SYNT
65
DELISTED
Syntel Inc
SYNT
| $798K | 0.09% |
31,270
| – | – |
2017 Q1
4 quarters
|
|
|
AKAO
66
DELISTED
Achaogen Inc
AKAO
| $777K | 0.09% |
60,000
| – | – |
2017 Q3
2 quarters
|
|
|
ADMS
67
DELISTED
Adamas Pharmaceuticals
ADMS
| $717K | 0.08% |
30,000
| – | – |
2017 Q3
2 quarters
|
|
68
DNOW Inc
DNOW
$2.83B
| $569K | 0.07% |
55,675
| – | – |
2014 Q2
15 quarters
|
|
69
Ocular Therapeutix
OCUL
$1.51B
| $521K | 0.06% |
80,011
| – | – |
2017 Q4
1 quarter
|
|
70
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $517K | 0.06% |
11,000
| – | – |
2017 Q2
3 quarters
|
|
71
Loews
L
$22.6B
| $482K | 0.06% |
9,700
| – | – |
2017 Q2
3 quarters
|
|
|
MON
72
DELISTED
Monsanto Co
MON
| $450K | 0.05% |
+3,860
| New | +$464K |
2018 Q1
0 quarters
|
|
73
Omnicom Group
OMC
$22.1B
| $400K | 0.05% |
5,500
+1,300
| +31% | +$97.5K |
2017 Q4
1 quarter
|
|
74
Capri Holdings
CPRI
$1.81B
| $327K | 0.04% |
5,260
| – | – |
2017 Q3
2 quarters
|
|
75
Usana Health Sciences
USNA
$287M
| $295K | 0.03% |
3,440
| – | – |
2017 Q4
1 quarter
|
|
Similar funds
TPW
EWA
DCM
BC
QIM
AIMC
F
AAM
Hikari Power's Q1 2018 Portfolio in Review
As of Q1 2018, Hikari Power held 107 positions worth $850M, up 0.33% from $847M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Hikari Power deployed $26.1M of net new capital in Q1 2018, opening 6 new positions and adding to 20 existing holdings. Its largest new stake was Nutrien: 376,360 shares worth $17.8M.
By sector, the portfolio is most concentrated in Financials at 38% of assets, down from 39% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was AMAG Pharmaceuticals, an estimated $614K trimmed.
- Hikari Power's largest Q1 2018 buy was Nutrien: 376,360 shares worth $17.8M.
- Hikari Power added most to GE Aerospace in Q1 2018, an estimated $3.66M increase.
- Hikari Power's biggest Q1 2018 reduction was AMAG Pharmaceuticals, cutting an estimated $614K.
- Hikari Power fully exited Potash Corp Of Saskatchewan in Q1 2018, selling an estimated $19.4M.
- Hikari Power's ten largest holdings make up 59% of its $850M portfolio in Q1 2018.
- Hikari Power opened 6 new positions and closed 10 in Q1 2018.
- Hikari Power's portfolio value rose 0.33% quarter-over-quarter to $850M.
Based on Hikari Power's 13F filing for Q1 2018, filed 14 May 2018.